01 HARMLESS DRUGS LANSOPRAZOLE PELLETS 8.33%. (1)
02 HARMLESS DRUGS LANSOPRAZOLE PELLETS 8.33% (1)
03 HARMLESS MEDICINE LANSOPRAZOLE PELLETS 8.33% (1)
04 LANSOPRAZOLE 8.5% EC PELLETS (MEIS SL.NO (1)
05 LANSOPRAZOLE 8.5% EC PELLETSS (MEIS UNDE R APPENDIX 3B S/L:1301) (1)
06 LANSOPRAZOLE 8.5% EC PELLETSS (MEIS UNDER APPENDIX 3B S/L:1301) (1)
07 LANSOPRAZOLE CAPSULES 30MG, 429000PCSOTH DET.AS PER P/LIST & INV NO.CP/EXP/6045/15-16 DT.05.03.2016 (1)
08 LANSOPRAZOLE CAPSULES 30MG, 549000PCSOTH DET.AS PER P/LIST & INV NO.CP/EXP/6041/15-16 DT.23.02.2016 (1)
09 LANSOPRAZOLE DELAYED RELEASE CAPSULES USP 30MG, 2227200PCS, OTH DET.AS PER P/LIST &INV NO.T002/004/16-17DT.21.04.16 (1)
10 LANSOPRAZOLE DELAYED RELEASE CAPSULES USP 30MG, 490000PC,OTH DET.AS PER P/LIST& INV NO.CP/EXP/6043/15-16 DT.26.02.2016 (1)
11 LANSOPRAZOLE DELAYED RELEASE CAPSULES USP 30MG, 795000PCS OTH DET.AS PER P/L.& INV NO.CP/EXP/6040/15-16DT.19.2.16 (1)
12 LANSOPRAZOLE DR PELLETS 8.5% IN HOUSE (1)
13 LANSOPRAZOLE E/C PELLETS 8.5% (2)
14 LANSOPRAZOLE EC PELLETS 8.5% (1)
15 LANSOPRAZOLE EC PELLETS 8.5% (2)
16 LANSOPRAZOLE PELLETS 8.33% (18)
17 LANSOPRAZOLE PELLETS 8.5% (1)
01 KGS (36)
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE